ArticleCase reports in oncology

Evidence of Efficacy for Neoadjuvant Immunochemotherapy in a Rare Subgroup: Two Cases of Pathological Complete Response in Locally Advanced HER2-Mutant NSCLC.

Haizhou Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.